Phase II trial of cetuximab in patients (pts) with metastatic and/or locally advanced soft tissue and bone sarcomas

H. T. Ha,Rashmi Chugh,Kent A. Griffith,Dafydd G. Thomas,Scott M. Schuetze,David R. Lucas,Janet Sybil Biermann,Mark M. Zalupski

Phase II trial of cetuximab in patients (pts) with metastatic and/or locally advanced soft tissue and bone sarcomas

2008

H. T. Ha
Rashmi Chugh
Kent A. Griffith
Dafydd G. Thomas
Scott M. Schuetze
David R. Lucas
Janet Sybil Biermann
Mark M. Zalupski

10537 Background: Cytotoxic therapy has resulted in limited improvement in outcomes of pts with advanced sarcoma. The epidermal growth factor receptor (EGFR) pathway plays a role in tumorigenicity ...

Keywords:

Cetuximab
Bone Sarcoma
Soft tissue
Medicine
Internal medicine
Oncology
Epidermal growth factor receptor
Cytotoxic Therapy
Sarcoma
locally advanced
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations